Prudential Financial Inc Protagonist Therapeutics, Inc Transaction History

Prudential Financial Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$10.78 - $25.38 $725,418 - $1.71 Million	67,293 New	67,293 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $162,330 - $586,781	-22,993 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$23.34 - $36.08 $165,994 - $256,600	-7,112 Reduced 23.62%	22,993 $544,000
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $3,349 - $7,049	-190 Reduced 0.63%	30,105 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $5,827 - $22,360	450 Added 1.51%	30,295 $537,000
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $96,398 - $169,197	-3,770 Reduced 11.22%	29,845 $1.34 Million
Q1 2021 May 12, 2021	SELL	$19.02 - $31.15 $194,194 - $318,041	-10,210 Reduced 23.3%	33,615 $871,000
Q4 2020 Feb 16, 2021	SELL	$18.49 - $25.13 $206,903 - $281,204	-11,190 Reduced 20.34%	43,825 $884,000
Q3 2020 Nov 16, 2020	SELL	$15.19 - $22.4 $186,685 - $275,296	-12,290 Reduced 18.26%	55,015 $1.08 Million
Q2 2020 Aug 12, 2020	SELL	$6.19 - $18.84 $31,166 - $94,859	-5,035 Reduced 6.96%	67,305 $1.19 Million
Q1 2020 May 12, 2020	BUY	$5.4 - $9.22 $111,510 - $190,393	20,650 Added 39.95%	72,340 $510,000
Q4 2019 Feb 11, 2020	BUY	$4.69 - $13.45 $185,677 - $532,485	39,590 Added 327.19%	51,690 $364,000
Q2 2018 Aug 13, 2018	SELL	$5.99 - $9.1 $8,805 - $13,377	-1,470 Reduced 10.83%	12,100 $0
Q1 2018 May 04, 2018	BUY	$8.46 - $23.08 $114,802 - $313,195	13,570 New	13,570 $0

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.34B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.